Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases
Reference6 articles.
1. SARS-CoV-2 B.1.617 mutations L452R and E484Q are not synergistic for antibody evasion;Ferreira;J Infect Dis,2021
2. The SARS-CoV-2 lambda variant exhibits enhanced infectivity and immune resistance;Kimura;Cell Rep,2022
3. Serum neutralization of SARS-CoV-2 omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies;Bruel;Nat Med,2022
4. Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA.2;Takashita;N Engl J Med,2022
5. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 omicron lineage strains;Case;bioRxiv,2022
Cited by 143 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination;Cell Discovery;2024-02-06
2. Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants;Viruses;2024-01-31
3. Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness;Viruses;2024-01-25
4. Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein;Antibodies;2024-01-05
5. In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates;Emerging Microbes & Infections;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3